KX
Konstantinos Xynos
Chief Medical Officer

Konstantinos Xynos insider trades: Replimune Group (REPL) stock sales

Chief Medical Officer, Replimune Group Last trade Aug 10, 2026 15 Form 4 filings
$286K
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Konstantinos reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 10, 2026REPL↓ Sell$148K
May 18, 2026REPL↓ Sell$71K
Nov 17, 2025REPL↓ Sell$66K
May 20, 2025REPL↓ Sell$64K
Nov 18, 2024REPL↓ Sell$78K
Jun 7, 2024REPL↓ Sell$119K
May 16, 2024REPL↓ Sell$41K
Nov 16, 2023REPL↓ Sell$80K
May 16, 2023REPL↓ Sell$14K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other REPL insiders

Open-market trades in the last 12 months

About Konstantinos Xynos's insider trades

Konstantinos Xynos is Chief Medical Officer at Replimune Group (REPL). Since May 16, 2023, Konstantinos has reported no open-market purchases and 9 sales worth $682K on SEC Form 4. In the last 12 months: 3 sales ($286K).

Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every REPL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.